Expert consensus on the detection and clinical management of familial hypercholesterolemia

被引：10

作者：

Masana, Lluis ^{[1
]}

Civeira, Fernando ^{[1
]}

Pedro-Botet, Juan ^{[1
]}

de Castro, Isabel ^{[1
]}

Pocovi, Miguel ^{[1
]}

Plana, Nuria ^{[1
]}

Mateo-Gallego, Rocio ^{[1
]}

Jarauta, Estibaliz ^{[1
]}

Pedragosa, Angels ^{[1
]}

机构：

[1] Soc Espanola Arteriosclerosis, Barcelona, Spain

来源：

CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS | 2013年 / 25卷 / 04期

关键词：

Familial hypercholesterolemia; Guidelines; Clinical management;

D O I：

10.1016/j.arteri.2013.07.005

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

Familial hypercholesterolemia (FH) is one of the most common and severe genetic diseases, causing disabilities and premature death to those who suffer it. Lipid-lowering therapy substantially improves the prognosis of FH patients and, therefore, appropriate pharmacological treatment is of the utmost importance. The Spanish Society of Arteriosclerosis (SEA) has always been a pioneer in the diagnosis and treatment of FH. Since its inception, FH has been one of the main areas of clinical and scientific interest, mainly for Lipids Units of the SEA, where most patients with this pathology are referred in Spain. This document arises from the willingness of our society to update the scientific knowledge on this subject and to provide physicians with clear clinical guidelines regarding diagnosis and treatment of FH. These guidelines can be summarized in two main aspects: early diagnosis of the disease and a rapid normalization of LDL cholesterol. In the coming years, health providers should accomplish that the majority of patients with FH are aware of their diagnosis and that adequate treatment is provided. (C) 2013 Elsevier Espana, S.L. y SEA. All rights reserved.

引用

页码：182 / 193

页数：12

共 47 条

[11]

Humphries S.E., Whittall R.A., Hubbart C.S., Maplebeck S., Cooper J.A., Soutar A.K., Et al., Simon Broome Familial Hyperlipidaemia Register Group and Scientific Steering Committee. Genetic causes of familial hypercholesterolaemia in patients in the UK: Relation to plasma lipid levels and coronary heart disease risk, J Med Genet, 43, pp. 943-949, (2006)

[12]

Civeira F., Ros E., Jarauta E., Plana N., Zambon D., Puzo J., Et al., Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia, Am J Cardiol, 102, pp. 1187-1193, (2008)

[13]

Junyent M., Gilabert R., Zambon D., Nunez I., Vela M., Civeira F., Et al., The use of Achilles tendon sonography to distinguish familial hypercholesterolemia from other genetic dyslipidemias, Arterioscler Thromb Vasc Biol, 25, pp. 2203-2208, (2005)

[14]

Alonso R., Mata N., Castillo S., Fuentes F., Saenz P., Muniz O., Et al., Cardiovascular disease in familial hypercholesterolaemia: Influence of low-density lipoprotein receptor mutation type and classic risk factors, Atherosclerosis, 200, pp. 315-321, (2008)

[15]

Austin M.A., Hutter C.M., Zimmern R.L., Humphries S.E., Genetic causes of monogenic heterozygous familial hypercholesterolemia: A HuGE prevalence review, Am J Epidemiol, 160, pp. 407-420, (2004)

[16]

McCrindle B.W., Familial hypercholesterolemia in children and adolescents, Curr Opin Lipidol, 23, pp. 525-531, (2012)

[17]

Wierzbicki A.S., Humphries S.E., Minhas R., Familial hypercholesterolemia: Summary of NICE guidance, BMJ, 337, (2008)

[18]

Descamps O.S., Tenoutasse S., Stephenne X., Gies I., Beauloye V., Lebrethon M.C., Et al., Management of familial hypercholesterolemia in children and young adults: Consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization, Atherosclerosis, 218, pp. 272-280, (2011)

[19]

Goldberg A.C., Hopkins P.N., Toth P.P., Ballantyne C.M., Rader D.J., Robinson J.G., Et al., National Lipid Association Expert Panel on Familial Hypercholesterolemia. Familial hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia, J Clin Lipidol, 5, SUPPL. 3, (2011)

[20]

Robinson J.G., Goldberg A.C., Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia, J Clin Lipidol, 5, SUPPL. 3, (2011)

← 1 2 3 4 5 →